Article Details
Retrieved on: 2021-03-06 07:00:23
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The biotechnology company reported ($0.41) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.74) by $0.33.
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here